BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Afferent Pharmaceuticals Announces Positive Results In Phase 2b Chronic Cough Trial

  September 28, 2015

   · 

  5 min read
• Drug Development

  New Data From KEYNOTE-028, Merck & Co.’s Trial Evaluating KEYTRUDA(Pembrolizumab) Across A Range Of Cancer Types, Presented At 2015 European Cancer Congress

  September 28, 2015

   · 

  13 min read
• Drug Development

  Triphase Accelerator Announces Phase 1 Study Results With Marizomib In Combination With Pomalidomide And Dexamethasone In Patients With Relapsed And Refractory Multiple Myeloma

  September 28, 2015

   · 

  4 min read
• Policy

  Bristol-Myers Squibb Announces FDA Regulatory Filing Update For The Opdivo+Yervoy Regimen In Patients With Previously Untreated Advanced Melanoma

  September 28, 2015

   · 

  1 min read
• Biotech Bay

  BioTime Agrees to Sell Up To $20.7 Million Of Common Shares

  September 28, 2015

   · 

  1 min read
• FDA

  Enanta Pharmaceuticals, Inc. Announces Approval Of VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) In Japan For The Treatment Of Genotype 1 Chronic Hepatitis C

  September 28, 2015

   · 

  9 min read
• Genetown

  Fractyl Announces Positive Results From 39-Patient Study Of Revita DMR System

  September 28, 2015

   · 

  4 min read
• FDA

  Takeda Pharmaceutical Co. Ltd.: New Drug Application Approval In Japan For Copaxone Subcutaneous Injection 20 Mg Syringe, A Drug For The Treatment Of Multiple Sclerosis

  September 28, 2015

   · 

  3 min read
• Drug Development

  Palatin Tech Release: Preclinical Data On PL-3994 For Heart Failure And Resistant Hypertension Presented At 2015 Heart Failure Society Of America Annual Meeting

  September 28, 2015

   · 

  4 min read
• Genetown

  Epizyme To Present Clinical Data From Ongoing Phase 1 Dose Escalation Trial Of Tazemetostat (EPZ-6438) At The European Cancer Congress

  September 28, 2015

   · 

  1 min read